Showing results (21-30 of 267) with videos related to

Sort By:
Pageof 27
Frontiers in Cardiovascular Medicine|December 9, 2021
Statins and Peripheral Arterial Disease: A Narrative ReviewSergio Jansen-Chaparro, María D López-Carmona, Lidia Cobos-Palacios, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 2, 2014
T cell-depleted related HLA-mismatched peripheral blood stem cell transplantation as salvage therapy for graft failure after single unit unrelated donor umbilical cord blood transplantationFederico Moscardó, Samuel Romero, Jaime Sanz, et al.
Plos One|January 26, 2012
Bone marrow-derived cells from male donors do not contribute to the endometrial side population of the recipientIrene Cervelló, Claudia Gil-Sanchis, Aymara Mas, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 5, 2013
Myeloablative cord blood transplantation in adults with acute leukemia: comparison of two different transplant platformsJaime Sanz, John E Wagner, Miguel A Sanz, et al.
Haematologica|May 14, 2011
Central nervous system involvement at first relapse in patients with acute myeloid leukemiaDavid Martínez-Cuadrón, Pau Montesinos, Mariluz Pérez-Sirvent, et al.
Antimicrobial Resistance and Infection Control|November 6, 2019
Genomic characterization of Citrobacter freundii strains coproducing OXA-48 and VIM-1 carbapenemase enzymes isolated in leukemic patient in SpainRym Lalaoui, Ana Djukovic, Sofiane Bakour, et al.
International Journal of Hematology|September 19, 2007
A study of incidence and characteristics of infections in 476 patients from a single center undergoing autologous blood stem cell transplantationNoemí Puig, Javier de la Rubia, Isidro Jarque, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 30, 2020
Reduced-Intensity versus Myeloablative Conditioning in Cord Blood Transplantation for Acute Myeloid Leukemia (40-60 years) across Highly Mismatched HLA Barriers-On Behalf of Eurocord and the Cellular Therapy & Immunobiology Working Party (CTIWP) of EBMTVipul Sheth, Fernanda Volt, Jaime Sanz, et al.
Pageof 27